{"id":"W4205527069","doi":"10.1182/blood.2021012743","title":"A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; NYU Grossman School of Medicine; Genentech; National Institutes of Health; Italfarmaco; Astellas Pharma; Rosetrees Trust; Cancer Research UK; Sierra Oncology; CTI Biopharma; Incyte; Tizona Therapeutics; Constellation Pharmaceuticals; Jazz Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Medical Research Council; Celgene; Gilead Sciences; Amgen","keywords":"Essential thrombocythemia; Polycythemia vera; Hydroxycarbamide; Adverse effect; Clinical endpoint; Phases of clinical research; Myelofibrosis; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001988392,0.001115779,0.00199883,0.0003808734,0.0004076159,0.0008426865,0.0006632383,0.00145412,0.005982819],"category_scores_gemma":[0.002385504,0.0005021261,0.001392999,0.000332123,0.0008071762,0.0007729558,0.0003479314,0.00287005,0.000630445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006284641,"about_ca_system_score_gemma":0.0009259749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009129054,"about_ca_topic_score_gemma":0.001770628,"domain_scores_codex":[0.999275,0.0005039289,0.00002876698,0.00007386342,0.0000378626,0.00008064284],"domain_scores_gemma":[0.9988176,0.0004814497,0.0002330462,0.00008149281,0.0000560776,0.0003302861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9815045,0.005622629,0.0003795948,0.0001777841,0.0004089375,0.00004298565,0.00003183783,0.0002921419,0.001589292,0.00009909718,0.0005729545,0.009278284],"study_design_scores_gemma":[0.9534247,0.04479718,0.0007610623,0.00001447636,0.0001031518,0.0000229606,0.00001002046,0.0003351164,0.000129716,0.0001287108,0.0002673805,0.000005518205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851313,0.002972268,0.0008912523,0.0009216116,0.0007381673,0.006198289,0.0008858845,0.0001295877,0.002131569],"genre_scores_gemma":[0.9815003,0.001713535,0.002290291,0.001850354,0.0004306367,0.007846945,0.001071052,0.00003268509,0.003264225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005982819,"threshold_uncertainty_score":0.02001452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01342696561876174,"score_gpt":0.2949706411374693,"score_spread":0.2815436755187076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}